Search clinical trials for: mebeverine 200 mg sustained-release (Coloverine® SR, Chemipharm pharmaceutical, Egypt) one time/day
Total 1 results
-
Mansoura UniversityCompletedUrinary Incontinence | Urinary Bladder Cancer | IncontinenceEgypt
Sponsors and Collaborators
- Genuv Inc.
- Liming Cheng
- Jia Liu
- Marcus Vinícius Guimarães de Lacerda
- Biorobotic Institute Scuola Superiore sant'Anna Pisa
- Hoersholm Hospital
- Kerstyn C. Zalesin, M.D.
- Only For Children Pharmaceuticals
- Sahar Salehi
- FutureGen Biopharmaceutical (Beijing) Co., Ltd
- Xiao-Ming Mao
- The People's Hospital of Guangxi Zhang Autonomous Region
- Pancreatic Cancer UK
- Royal Hobart Hospital Research Foundation (funding source)
- Klinikum Bad Woerishofen
- Egyptian Russian University
- Kuwait University
- Hopeful Aging
- Friedrich Miescher Institute for Biomedical Research (FMI)
- Van Boven, Robert W., M.D.
- View Full List
Medical Conditions
- Autologous Haematopoietic Stem Cell Transplant
- Stage II Vulvar Cancer
- Caffeine Dosage
- Using Imagery to Maintain Muscle Mass Gains in the Quadriceps
- Pulmonary Invasive Aspergillosis
- Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
- Smith-Lemli-Opitz Syndrome
- Stereotype-threat
- Enlarged Uterus
- Urinary Tract Carcinoma
- Airway Obstruction
- Gait Variability; Elders; Fall; Re-education
- Pancytopenia Due to Chemotherapy
- High Perinatal Mortality
- Global Health
- Advanced Gastric Cancer With Serosal Invasion
- Role of Vitamin D in IVF for Better Outcome
- Raynaud Secondary to Other Autoimmune Disease
- EHMT1
- Secondary Hypertension to Endocrine Disorders
- View Full List
Drug Interventions
- MC-1101
- APD334
- Ibudilast
- Vehicle Foam with UVA and UVB and visible light irradiation
- ACP-204
- Ustekinumab
- IBI318
- Jatenzo
- Iohexol Inj 300 MG/ML
- P276-00
- Nystatin
- Omalizumab Injection
- RDEA3170 12 mg
- Androgen-deprivation Therapy (ADT)
- Naltrexone and bupropion SR
- LX4211 800 mg
- Olopatadine hydrochloride ophthalmic solution 0.7%)
- CAZ/AVI plus Aztreonam
- Clostridium Botulinum Toxin Type A (Nabota, DWP 450) 50 U
- High-dose loop diuretics
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Hungary
- Contract Research Organizations in Italy
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Moldova
- Contract Research Organizations in Philippines
- Contract Research Organizations in Romania
- Contract Research Organizations in Singapore
- Contract Research Organizations in South Korea
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in United Kingdom
- CRO list by country